Vertical: CFnBBase Year: 201813 Sections
Market Size (2018)
$13.49B
Projected (2025)
$20.71B
CAGR (2017–2025)
6.3%
Key Players
10+
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} The global multivitamin capsules and tablets market was valued at USD 13,485.9 million in 2018 and is expected to register a substantial growth rate of 6.33% during the forecast period. The rising prevalence of vitamin deficiencies among the population owing to lack of appropriate amount of nutrients through daily diets is driving the growth of the multivitamin capsules and tablets market. Moreover, increasing health consciousness and the expansion of fitness centers and health clubs support the demand for multivitamin capsules and tablets. However, the side effects associated with the overconsumption of multivitamin capsules and tablets are restraining the growth of the market.
The Multi Vitamin Capsules Tablets Market market is projected to grow at a CAGR of 6.3% from 2017 to 2025.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansNormal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Multivitamin capsules and tablets are dietary supplements that help meet the daily requirements for essential nutrients. These capsules and tablets are formulated to promote immune health, support bone health, and provide energy and brain support.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2017 – 2017
Forecast Period
2019 – 2025
Primary Interviews
150+
Historical data (2017–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansNormal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} The global multivitamin capsules and tablets market is projected to register a CAGR of 6.33% during the review period. The growth of the market can be attributed to the increasing health awareness among consumers, high prevalence of vitamin deficiencies, and expansion of the retail sector. Market players are expected to witness profitable growth opportunities in the global market due to the rising demand for multivitamin capsules and tablets.
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} The key players operating in the global multivitamin capsules and tablets market include The Nature's Bounty Co. (US), Glanbia plc (Ireland), Herbalife Nutrition Ltd. (US), GlaxoSmithKline plc (UK), Abbott Laboratories (US), Amway Corp (US), Bayer AG (Germany), Otsuka Holdings Co., Ltd (Japan), Nature's Way Products, LLC (US), and Nu Skin Enterprises, Inc. (US). The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have a global reach along with diverse product portfolios. Companies such as The Nature's Bounty Co., Bayer AG, GlaxoSmithKline plc, Nu Skin Enterprises, Inc., and Nature's Way Products, LLC dominate the global market due to brand reputation, product differentiation, financial stability, and diversified regional presence.
The players are focused on investing in research and development and adopting strategic growth initiatives such as acquisitions, product launches, and expansions to strengthen their market position and capture a large customer base.
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Michael Porter’s Five Forces model offers a framework to study the global multivitamin capsules and tablets market. Strategic business managers, trying to gain an edge over competing firms in the global multivitamin capsules and tablets market, can utilize this model to better comprehend the industry in which the company operates. The components of each of the forces and the degree of impact of each element in the context of the global multivitamin capsules and tablets market have been broken down and analyzed.
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;}
Threat of New Entrants
The global multivitamin capsules and tablets market is highly lucrative with numerous revenue opportunities owing to the growth potential. The major players dominate the market owing to brand recognition making it difficult for new entrants to establish themselves. The capital investment is high in the market. The need for high initial investments due to raw material costs, certification costs, and approvals from regulatory bodies restrict the entry of new players. This makes it difficult for them to achieve economies of scale which the established players already possess.
Hence, the threat of new entrants in the global multivitamin capsules and tablets market is expected to be low.
Bargaining Power of Suppliers
The suppliers in the global multivitamin capsules and tablets market are chemical manufacturers, traders, distributors, importers, and independent suppliers. There are several suppliers present across the globe with limited raw material differentiation. This lowers the switching cost for multivitamin supplement manufacturers. Moreover, the market players tend to enter into long-term contracts with suppliers and maintain strong relationships to ensure uninterrupted supply of raw materials.
Hence, the bargaining power of suppliers in the global multivitamin capsules and tablets market is expected to be low.
Threat of Substitutes
There are no direct substitutes available for multivitamin supplements. However, there is internal substitution with other forms of multivitamins available in the market such as powder, liquid, and gummies. This has led market players to diversify their portfolios to include alternative forms of multivitamins.
Hence, the threat of substitutes in the global multivitamin capsules and tablets market is expected to be moderate.
Bargaining Power of Buyers
There is a large number of multivitamin supplement brands available in the market. Moreover, high awareness among consumers and low brand loyalty increase the bargaining power of the buyers by reducing the switching costs. With high buyer concentration manufacturers face pressure to offer high-quality products at low prices.
Hence, the bargaining power of buyers in the global multivitamin capsules and tablets market is expected to be high.
Intensity of Rivalry
With a large number of players present in the market, the multivitamin capsules and tablets industry is marked by high intensity of rivalry. There is a high level of competition among the market players in terms of product quality and variety. The key players invest in research and development to bring about innovation in their product lines and make product development a priority to meet changing consumer preferences.
Hence, the intensity of rivalry in the global multivitamin capsules and tablets market is expected to be high.
Market estimates by geography (2025)
InsightAsia Pacific leads with $7.84B by 2025.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2017 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $4.28B | $5.42B | $6.88B | 6.1% | 33% |
| Europe | $3.02B | $3.86B | $4.94B | 6.4% | 24% |
| Asia Pacific | $4.75B | $6.09B | $7.84B | 6.5% | 38% |
| Rest of the World | $643.76M | $816.27M | $1.04B | 6.2% | 5% |
| Total | $12.70B | $16.18B | $20.71B | 6.3% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$20.71B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Unisex | $12.35B | 6.2% | 60% |
| Women | $4.68B | 6.5% | 23% |
| Men | $3.68B | 6.4% | 18% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Multi Vitamin Capsules Tablets Market covering market dynamics, competitive landscape, and strategic outlook.
The Multi Vitamin Capsules Tablets Market market is projected to reach $20.71B by 2025, growing at 6.3% CAGR. The Unisex segment holds the largest share.
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} The global multivitamin capsules and tablets market is expected to register a notable growth rate during the forecast period. Increasing health consciousness and the expansion of fitness centers and health clubs support the demand for multivitamin capsules and tablets. Moreover, market players may benefit from offering multivitamin capsules and tablets targeted at the female population. However, awareness regarding the side effects associated with overconsumption of multivitamins is restraining the growth of the market.
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} In recent years, there has been a rise in the prevalence of vitamin deficiencies due to hectic lifestyles, shortened mealtimes, and loss of nutrition during cooking and processing of food. However, consumer awareness regarding this has increased resulting in a focus on the intake of multivitamins. Knowledge of diseases caused by vitamin deficiency is also propelling consumers to adopt multivitamins in their busy lifestyles. Consumers are looking for vitamin-rich food & beverages such as multivitamin supplements, sports nutrition products, and ready meals, which offer the right amount of health benefits and nutrition. Hence, with the increased consumption of vitamin-rich products by the health-conscious population, the demand for multivitamin capsules and tablets has grown.
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} In the past, the multivitamin capsules and tablets available in the market were unisex. However, there has been a shift in fitness trends with more women inclined toward sports and physical activities although this market segment remains largely untapped. Women are increasingly focusing on weight management and resistance training. The number of women participating in sports and fitness programs has increased in recent years. This offers manufacturers of multivitamin capsules and tablets the opportunity to widen their customer base by launching products aimed at women. Social media also plays a vital role in helping market players raise awareness about specific products and target certain consumer groups, especially in developing countries such as India and Brazil.
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} While the consumption of multivitamin supplements is increasing among all age groups, there are certain side effects associated with the overconsumption of these multivitamin capsules and tablets. Certain fat-soluble vitamins, such as vitamins A, E, D, and K, can easily build up to toxic levels in the body leading to a medical condition known as hypervitaminosis. For instance, overconsumption of vitamin A can cause dizziness, nausea, headaches, skin irritation, and joint pain whereas vitamin D toxicity cause calcium buildup or hypercalcemia, which leads to nausea, vomiting, weakness, and frequent urination. These symptoms might progress to bone pain and kidney problems, such as the formation of calcium stones. Similarly, very high doses of water-soluble vitamins can also become toxic. For example, very large amounts of vitamin C could cause nausea, diarrhea, and stomach cramps. Similarly, very high doses of vitamin B6 can lead to irreversible nerve damage while niacin (B3) can cause liver damage. The growing awareness regarding these side effects is likely to hamper the growth of the market during the forecast period.
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} The manufacture and sales of multivitamin capsules and tablets are subject to strict government regulations. Organizations such as the US Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) are responsible for controlling permits, setting regulations for the entry of new players, residual management issues, and inspection of expiry dates for the products such as multivitamin capsules and tablets. The FDA has set standards for regulating the manufacture and distribution of functional foods and vitamins in the US, while the EFSA has several regulations concerning the raw materials used in nutraceutical production, the production process, and labeling. The regulations governing multivitamin capsules and tablets vary with each country making it difficult for manufacturers to adopt standard operating procedures. For instance, in India, multivitamin supplement manufacturers need to follow the regulations laid down by the Food Safety and Standards Authority of India (FSSAI), which stipulates the quantity of nutrients to not exceed the recommended dietary allowance (RDA). However, the RDA itself varies from country to country owing to the different regulations specified by respective authorities. Such stringent government regulations pose a significant challenge to players in the global multivitamin capsules and tablets market.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 103 companies operating in the Multi Vitamin Capsules Tablets Market market, including revenue, employee count, and market positioning where available.
Showing 103 of 103 companies
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: California, US Founded: 1980 Workforce: ~8,900 Company Working: Herbalife Nutrition Ltd. is a manufacturer and supplier of protein shakes and snacks, vitamins and dietary supplements, energy and fitness drinks, and skin and hair care products. It markets products targeted at weight management, sports and fitness, energy and targeted nutrition, and personal care (outer nutrition). These products are sold in 93 countries through a network of approximately four million sales representatives, sales officers, and independent service providers, most of whom are discount customers. Under the targeted nutrition category, Herbalife Nutrition Ltd. markets dietary and nutritional supplements designed to meet customers' specific nutritional needs. The energy, sports and fitness category of the company offers products that support a healthy active lifestyle. The company’s outer nutrition portfolio includes facial skincare, body care, and hair care products. The company sells start-up kits, sales tools, and educational materials through its literature, promotional and other category. The category also provides Internet-based tools such as BizWorks, a customizable retail website for its members.
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: New York, US Founded: 1971 Workforce: ~4,000 Company Working: The Nature's Bounty Co. (Nature’s Bounty) operates as a subsidiary of The Carlyle Group. It manufactures vitamins, nutritional supplements, herbs, sports and active nutrition products, and ethical beauty products in the US and internationally. The company offers its products under 20 different brands including Nature's Bounty, Pure Protein, Solgar, Osteo Bi-Flex, Dr.Organic, Sundown, Body Fortress, MET-Rx, and Ester-C. It offers products through retail and online stores. The company has manufacturing, packaging, warehouse, distribution, and administrative facilities across the US, Canada, and the UK. Additionally, it owns distribution offices in Spain, the Netherlands, New Zealand, and South Africa.
HP Inc. is the world's second-largest personal computer vendor and the largest printer vendor, operating a two-engine business model in which a large, low-margin, share-defending Personal Systems franchise is funded and cross-subsidised by a smaller, structurally declining but highly profitable Printing franchise built on consumables annuity economics. In FY2025 Personal Systems produced 70% of revenue at a 5.3% pre-tax segment margin while Printing produced 30% of revenue at an 18.7% margin, meaning Printing generated roughly 62% of total segment earnings on less than a third of the revenue. Management's declared strategy — "leading the Future of Work" — attempts to convert that hardware base into an AI-enabled, subscription-weighted platform through AI PCs, the Workforce Experience Platform, Poly collaboration hardware and the newly announced HP IQ intelligence layer. As of September 2026 the company is executing this transition under an interim chief executive, amid an acute DRAM/NAND cost shock and a formal search for a permanent CEO. HP Inc. is the Palo Alto–headquartered personal-computing and imaging/printing company that emerged from the November 2015 separation of the former Hewlett-Packard Company into two independent public companies. HP Inc. retained the legacy corporate registrant — it is the same legal entity as the original Hewlett-Packard Company, renamed — while the enterprise infrastructure, software and services businesses were spun into Hewlett Packard Enterprise Company. That legal continuity matters: HP Inc.'s SEC filings carry the original Commission file number and the original Delaware incorporation and IRS identification numbers, and the Form 10-K explicitly states that references to HP Inc. mean HP Inc. "(formerly Hewlett-Packard Company)" and its consolidated subsidiaries. --- ### HP's own description The FY2025 Form 10-K opens with the company's self-characterisation: HP describes itself as a global technology leader creating solutions that let people bring ideas to life and connect to what matters most, operating in more than 170 countries and delivering devices, services and subscriptions across personal computing, printing, 3D printing, hybrid work, gaming and adjacent technologies. The filing places artificial intelligence at the centre of its narrative, arguing that AI is transforming how people live and work and that customers are beginning to recognise benefits in security, speed and cost. It highlights a portfolio of AI PCs and workstations built for local AI processing, intelligent print features across home, office and graphics products, and a layered security proposition spanning security-enhanced PCs and printers, hardware-enforced endpoint security software for both HP and non-HP PCs, and endpoint security services using containment, isolation and AI deep-learning malware detection. Newer 2026 press-release boilerplate has tightened this language considerably: HP now describes itself as "a global technology leader redefining the Future of Work," operating in more than 180 countries and delivering AI-powered devices, software, services and subscriptions. The shift from "innovative and sustainable devices, services and subscriptions" (FY2025 10-K) to "innovative and AI-powered devices, software, services and subscriptions" (2026 releases) is a deliberate repositioning of the equity story from sustainability-and-devices to AI-and-software. ### Independent characterisation HP is best understood as three economically distinct businesses reported through two material segments. **The PC business is a scale-and-distribution business, not a technology business.** HP designs and specifies; it does not manufacture. The 10-K states plainly that HP uses outsourced manufacturers worldwide to build HP-designed products, relying on original manufacturers ("OMs") — with Taiwanese contract manufacturers named specifically for notebooks — and that HP represents a substantial portion of the business of certain OMs. Silicon comes from Intel, AMD and NVIDIA, with Qualcomm Snapdragon in selected Arm-based models; operating systems come from Microsoft and Google. HP's value-add is industrial design, security firmware, channel reach, procurement leverage, services attach and brand. The consequence is that HP's PC gross margin is a spread between component cost and street price, with very little insulation when component costs move violently — which is precisely what has happened in FY2026. **The printing business is a razor-and-blades annuity.** Supplies alone generated $10,916 million in FY2025, 65% of total Printing segment revenue and 19.7% of consolidated revenue, at margins far above the hardware. Printing's 18.7% FY2025 pre-tax segment margin is not an operating-leverage outcome; it is a consumables monopoly outcome, defended by supplies authentication technology ("Dynamic Security") which is itself the subject of persistent litigation and regulatory attention across multiple jurisdictions. The 10-K's own risk factors concede the structural problem in unusually direct language: secular decline in print demand from digitisation and hybrid work, competition from generic and remanufactured supplies, and customer migration from cartridge printers to refillable "big tank" printers which — HP states explicitly — carry higher initial hardware margin but "do not result in follow-on sales of high margin traditional ink cartridges and, as a result, may have lower overall device lifetime profitability." That is management admitting that its own product-mix shift is dilutive to lifetime economics. **The services, software and subscription overlay is the strategic bet.** This spans HP Instant Ink and the HP All-In Plan on the consumer side; managed print services, Device-as-a-Service and lifecycle services on the commercial side; the Workforce Experience Platform (WXP), Poly Lens and Wolf Security on the software side; and Poly hardware in meeting rooms. HP does not disclose a discrete revenue line for "subscriptions" or "software" in its segment note, which is a material transparency gap for anyone underwriting the transition thesis. The company reports only Commercial PS, Consumer PS, Supplies, Commercial Printing, Consumer Printing and Corporate Investments. ### Value chain position and route to market HP sits between component suppliers and a multi-tier distribution network, owning almost none of the physical production. The 10-K describes four channel archetypes — retailers, value-added resellers, distribution partners and systems integrators — and states that the majority of overall revenue is transacted through channel resellers, with direct/indirect mix varying by business and geography. This creates two structural exposures the filings acknowledge repeatedly: limited visibility into multi-tier channel inventory, and the risk of channel partners selling outside agreed territories or misrepresenting sell-through, which HP states has occurred historically and has damaged gross margins. Customer concentration is now material and newly so. The FY2025 segment note discloses that TD Synnex Corp accounted for 12% of HP's net revenue in FY2025, whereas no single customer represented 10% or more in FY2024 or FY2023. That is a new disclosure threshold crossing and a genuine concentration risk that did not exist twelve months earlier. ### Customer types and end markets Commercial customers span large enterprise, public sector (including education), and small and medium business, served with the Pro and Elite PC portfolios, Z workstations, thin clients, retail point-of-sale, and managed lifecycle services. Consumer customers are served through gaming (OMEN, Victus, HyperX), mainstream and premium notebooks (OmniBook, Envy, Pavilion, Spectre lineage), Chromebooks and home printing. Industrial and graphics end-markets — print service providers, packaging converters, commercial publishers, production mail — are addressed through Indigo, PageWide and Latex presses. Additive manufacturing customers are served through Multi Jet Fusion and Metal Jet.
Company Headquarters: US Founded: 1847 Workforce: ~+79800 employees Company Working: Philip Morris International (PMI) is a leading multinational tobacco company. PMI's primary business is the manufacturing and sale of cigarettes. The company's portfolio includes renowned brands such as Marlboro, Parliament, L&M, Chesterfield, and Philip Morris. PMI has been actively investing in and developing reduced-risk products (RRPs) as alternatives to traditional cigarettes. The flagship RRP is the IQOS system, which heats tobacco rather than burning it. PMI operates in over 180 countries, making it one of the largest international tobacco companies. The company has a strong market presence in key regions, including the European Union, Asia Pacific, Latin America, the Middle East, and Africa.
Company Headquarters: Japan Founded: 1999 Workforce: ~52640+ employees Company Working: Japan Tobacco International (JTI) is one of the leading international tobacco company. JTI was formed in 1999 as a result of the privatization of the Japanese government-owned tobacco monopoly. The company operates in over 130 countries and has a strong presence in both developed and emerging markets. JTI's primary business is the manufacturing and sale of cigarettes. The company offers a wide range of cigarette brands, including Winston, Camel, Mevius (formerly Mild Seven), and LD. JTI has also ventured into the reduced-risk products market, with its Ploom Tech and Ploom S products that use heated tobacco technology. JTI has a significant global presence, with operations across Asia, Europe, the Americas, the Middle East, and Africa. The company has manufacturing facilities in various countries to cater to local demand and ensure efficient supply chain management.
10 interactive charts drawn from the Multi Vitamin Capsules Tablets Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Multi Vitamin Capsules Tablets Market South America, Middle-East and Africa Of Rest Of The World
Global Multi Vitamin Capsules Tablets Market China, India, Japan, Rest Of Asia Pacific and Australia And New Zealand Of Asia Pacific By Country
Global Multi Vitamin Capsules Tablets Market Germany, Spain, France, United Kingdom, Italy and Rest Of Europe By Country
Global Multi Vitamin Capsules Tablets Market United States, Canada and Mexico Of North America By Country
Global Multi Vitamin Capsules Tablets Market By Region
Multi Vitamin Capsules Tablets Market Rest Of The World
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
